Requip and Multiple sclerosis aggravated - a phase IV clinical study of FDA data

Summary:

Multiple sclerosis aggravated is reported as a side effect among people who take Requip (ropinirole hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for 5 - 10 years also take Tecfidera, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Multiple sclerosis aggravated when taking Requip. It is created by eHealthMe based on reports of 21,866 people who have side effects when taking Requip from the FDA, and is updated regularly.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

What is Multiple sclerosis aggravated?

Multiple sclerosis aggravated (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,023 drugs and 323 conditions by eHealthMe. Check the latest studies of Multiple sclerosis aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

21,866 people reported to have side effects when taking Requip.
Among them, 80 people (0.37%) have Multiple sclerosis aggravated.

Could Requip cause Multiple sclerosis aggravated?

Among these 80 people:

How long have people been on Requip when they have Multiple sclerosis aggravated? *

What is the gender of people who have Multiple sclerosis aggravated when taking Requip? *

female: 87.18 %
male: 12.82 %

What is the age of people who have Multiple sclerosis aggravated when taking Requip? *

What are other drugs people take besides Requip? *

What are other side effects people have besides Multiple sclerosis aggravated? *

Fatigue (feeling of tiredness): 16 people, 20.00%
Fall: 15 people, 18.75%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 14 people, 17.50%
Memory Loss: 13 people, 16.25%
Weakness: 12 people, 15.00%
Gait Disturbance: 12 people, 15.00%
High Blood Pressure: 9 people, 11.25%
Pain: 9 people, 11.25%
Tremor (trembling or shaking movements in one or more parts of your body): 9 people, 11.25%
Pneumonia: 9 people, 11.25%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 11 people, 13.75%
Depression: 8 people, 10.00%
High Blood Pressure: 6 people, 7.50%
Gait Disturbance: 6 people, 7.50%
Stress And Anxiety: 5 people, 6.25%
Pain: 4 people, 5.00%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 5.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 5.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 5.00%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Requip and have Multiple sclerosis aggravated?

- Check whether Multiple sclerosis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Requip:

Requip (22,950 reports)

Browse all side effects of Requip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple sclerosis aggravated:

Multiple sclerosis aggravated (1,023 drugs)

Browse all the conditions that are associated with Multiple sclerosis aggravated:

Multiple sclerosis aggravated (323 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ropinirole hydrochloride (the active ingredients of Requip) and Requip (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.